Harrow Health Inc (HROW)

NASDAQ
10.870
+0.180(+1.68%)
After Hours
10.600
-0.270(-2.484%)
- Real-time Data
  • Volume:
    31,121
  • Day's Range:
    10.610 - 10.870
  • 52 wk Range:
    5.400 - 13.286

HROW Overview

Prev. Close
10.69
Day's Range
10.61-10.87
Revenue
86.97M
Open
10.76
52 wk Range
5.4-13.286
EPS
-0.828
Volume
31,121
Market Cap
297.99M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
200,615
P/E Ratio
-12.65
Beta
0.4
1-Year Change
5.84%
Shares Outstanding
27,413,654
Next Earnings Date
Mar 09, 2023
What is your sentiment on Harrow Health?
or
Market is currently closed. Voting is open during market hours.

Harrow Health Inc News

Harrow Health Inc Analysis

Harrow Health Inc Company Profile

Harrow Health Inc Company Profile

Employees
182

Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc., a commercial-stage pharmaceutical company that engages in developing and commercializing drug products. Harrow Health, Inc. owns royalty rights in four clinical stage drug candidates being developed by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Read More

Analyst Price Target

Average16.625 (+52.94% Upside)
High17
Low16
Price10.87
No. of Analysts4
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuyBuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuySellStrong Buy
SummaryStrong BuyStrong BuyStrong BuyNeutralStrong Buy
  • Set Bracket PriceH$8.76 = BuyL$7.76 = Sell
    0
    • Corporate Insiders Bought Shares Worth $660.4K in the Last 3 Months. Since these last inside trades, the stock price opened at $7.32 on 7.21 and closed at $8.26 on 7.23 an 13% increase.
      0
      • Does anyone own this?
        0
        • Upside potential here
          0